Harry Winston Diamond Corp.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Harry Winston Diamond Corp.
Focusing too much on the US provides a blinkered view of the industry and prevents access to the myriad opportunities on offer globally.
Private Company Edition: Arvelle, insitro, AbCellera and the University of Michigan have something in common – they each attracted more than $100m in venture capital investment.
A transatlantic initiative is screening a US library of 15,000 pharmacologically active compounds for anti-COVID-19 activity, using artificial intelligence technologies.
Vant deal, discovery platforms help Japanese firm build out pipeline before it faces the first expiries for its top seller.